A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Food manufacturers are trying to whip themselves up a forkful of the slimming trend — but nutrition experts aren't giving ...

More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...

此前有报道称，礼来现已占据了美国减肥药市场约40%的份额。分析师预计，到2024年底，诺和诺德和礼来在减肥市场的份额将大致“平分秋色”，一旦产能跟上，这种势均力敌的状态有可能被打破，礼来有望取而代之。

Nina King says that Ozempic's rise could shift beauty standards away from thinness as it becomes more accessible.

A mom of two is getting her exercise by cleaning her house. It's something Melissa Floro says she didn't have the energy to ...

GLP-1 agonists like Ozempic effectively help manage obesity, but quitting the medication can lead to a resurgence in weight ...

两项重磅试验2025年揭晓 ...

Ozempic has fast become a household name. In addition to helping people with diabetes manage their blood sugar levels, this ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Two new studies suggest that the diabetes medication Ozempic may double the risk of a rare but serious condition that damages ...

世界首富埃隆·马斯克周三在社交媒体平台X上透露，他正在使用礼来公司的Mounjaro来减肥。他在平台上发布了一张自己打扮成圣诞老人的照片，站在一棵圣诞树旁，并配文“Ozempic圣诞老人”。随后，他又发帖称：“就像可卡因熊，不过这是圣诞老人和Ozem ...